PREMISE — tracking PrEP use across the U.S.
Establishing PREMISE: A PrEP Epidemiology, Modeling, and Surveillance System
['FUNDING_R01'] · EMORY UNIVERSITY · NIH-11169923
This project brings together national prescription and policy data to track who is using HIV prevention medication (PrEP) and which local programs help people access it.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | EMORY UNIVERSITY (nih funded) |
| Locations | 1 site (ATLANTA, UNITED STATES) |
| Trial ID | NIH-11169923 on ClinicalTrials.gov |
What this research studies
From your perspective, this project pulls together national PrEP prescription records, local program information, and laws to map where and how PrEP is being used. The team will code policies and programs across states and counties and use comparisons over time to see which changes lead to more people starting PrEP. They will build the PREMISE surveillance system to monitor PrEP scale-up, identify gaps in access, and inform public health efforts. Results will be shared with health departments and community groups to help improve local PrEP programs.
Who could benefit from this research
Good fit: People at risk for HIV or anyone interested in better access to PrEP and local prevention programs are the population this work is intended to inform.
Not a fit: People who are not at risk for HIV, who live outside the U.S., or who already have stable prevention in place may see little direct benefit from this project.
Why it matters
Potential benefit: If successful, this work could help target programs and policies that increase PrEP access and reduce new HIV infections.
How similar studies have performed: Researchers have previously used national prescription datasets and found links between assistance programs and higher PrEP use, but comprehensive, coded policy surveillance at this scale is relatively new.
Where this research is happening
ATLANTA, UNITED STATES
- EMORY UNIVERSITY — ATLANTA, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: SIEGLER, AARON JULIUS — EMORY UNIVERSITY
- Study coordinator: SIEGLER, AARON JULIUS
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Acquired Immune Deficiency Syndrome Virus, Acquired Immunodeficiency Syndrome Virus, Communicable Diseases